CNIO Art 2019

Home | News | Publications


Elena Castro and David Olmos Translational
Journal of Clinical Oncology. CNIO researchers confirm links between aggressive prostate cancer and hereditary breast cancer Aggressive prostate cancer, one of the leading causes of cancer deaths in men, is associated with...
p62 Basic Research
Cancer Cell. Researchers from the CNIO and the Hospital 12 de Octubre make sense out of the chaos of melanoma Unlike other skin cancers – and without knowing really why – melanoma is one of the most...
Mielofibrosis Translational
Haematologica. The CNIO and Hospital 12 de Octubre find a potential new combination therapy against a rare disease of the bone marrow Myelofibrosis is a severe and very rare haematological disease for which treatment has only been...
Lung Cancer Clinical Research Unit H12O-CNIO Innovation
The New England Journal of Medicine (NEJM). An international clinical trial extends the effectiveness of immunotherapy to more lung cancer patients The strategy for triggering the patient’s own immune system to attack cancer, immunotherapy, is...
H12O-CNIO Haematological Malignancies Clinical Research Unit Innovation
Haematologica. A new methodology predicts the risk of relapse in patients with acute myeloid leukemia The acute myeloid leukemia (AML) is the most common haematological cancer in adults. With a 5-year...
David Olmos Innovation
European Urology. First blood-based biomarker in response to the treatment of the most aggressive prostate cancer In collaboration with British and Italian researchers
Trombocitopenia-2 Basic Research
Journal of Clinical Investigation. CNIO finds the origin of a type of thrombocytopenia caused by an oncogene The Cell Division and Cancer Group of the Spanish National Cancer Research Centre (CNIO) has...
Basic Research
Nucleic Acids Research. An international team led by the CNIO reveals that human genome could contain up to 20% fewer genes A new study led by the Spanish National Cancer Research Centre (CNIO) reveals that up to 20% of...
first indicators of prognosis for the most aggressive type of breast cancer Innovation
Nature Communications. CNIO researchers find the first indicators of prognosis for the most aggressive type of breast cancer The rarest, but also the most aggressive and hard to treat form of breast cancer, is known as triple...